Fixed Price IPO | ₹8 Cr | Listed at BSE SME | Mon, Sep 25, 2017 - Wed, Sep 27, 2017
Vanta Bioscience IPO is a fixed price issue of ₹7.56 crores. The issue is entirely a fresh issue of 0.15 crore shares of ₹7.56 crore.
Vanta Bioscience IPO bidding started from Sep 25, 2017 and ended on Sep 27, 2017. The shares got listed on BSE SME on Oct 6, 2017.
Vanta Bioscience IPO price is ₹50 per share. The lot size for an application is 3,000. The minimum amount of investment required by an individual investor (retail) is ₹1,50,000 (3000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (6,000 shares), amounting to ₹3,00,000.
Inventure Merchant Banker Services Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Inventure Growth & Securities Ltd..
Refer to Vanta Bioscience IPO RHP for detailed Information.
IPO Open
Mon, Sep 25, 2017
IPO Close
Wed, Sep 27, 2017
Issue Price
₹50 per share
Market Cap (Pre-IPO)
₹28.64 Cr
| IPO Date | 25 to 27 Sep, 2017 |
| Listed on | Fri, Oct 6, 2017 |
| Face Value | ₹10 per share |
| Issue Price | ₹50 per share |
| Lot Size | 3,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Total Issue Size | 15,12,000 shares (agg. up to ₹8 Cr) |
| Reserved for Market Maker | 78,000 shares Inventure Growth & Securities Ltd. (agg. up to ₹0.3900 Cr) |
| Fresh Issue (Ex Market Maker) | 14,34,000 shares (agg. up to ₹7 Cr) |
| Net Offered to Public | 14,34,000 shares (agg. up to ₹7 Cr) |
| Share Holding Pre Issue | 42,16,000 shares |
| Share Holding Post Issue | 57,28,000 shares |
| BSE Script Code | 540729 |
| ISIN | INE695X01011 |
Vanta Bioscience IPO comprises a total issue size of 15,12,000 shares. The net offer to the public is 14,34,000 shares, after excluding 78,000 shares allotted on a firm basis. Of the Net offer 7,17,000 (50.00%) allocated to NII 7,17,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 7,17,000 | 50.00% | 47.42% |
| Retail Shares Offered | 7,17,000 | 50.00% | 47.42% |
| Firm Reservations | |||
| Market Maker Shares Offered | 78,000 | 5.16% | |
| Total Shares Offered | 15,12,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 3,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹1,50,000 |
| Retail (Max) | 1 | 3,000 | ₹1,50,000 |
| HNI (Min) | 2 | 6,000 | ₹3,00,000 |
Incorporated in 1995, Vanta Bioscience Ltd (VBL) is a preclinical contract research company which offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition they also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBL also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.
One of the major services of VBL is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Toxicology and safety assessment are sometimes used interchangeably and considered as synonymous.
Vanta Bioscience based in Des Moines, Iowa with additional offices in Brussels, Belgium; and West Des Moines, Iowa. It has a toxicology research facility in Chennai, India.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Augmenting additional working capital requirements | 6.79 |
| 2 | General Corporate Purposes | 0.27 |
The Vanta Bioscience IPO is subscribed [.] times on September 27, 2017 5:00:00 PM (Day 3). The public issue subscribed [.] times in the retail category, [.] times in the QIB category, and [.] times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Payment to Merchant Banker including, underwriting and selling commissions, brokerages, Advisors to the Company, payment to other intermediaries such as Legal Advisors, Registrars etc. and other out of pocket expenses | 0.25 |
| 2 | Advertising and marketing expenses | 0.03 |
| 3 | Printing and stationery expenses, distribution and postage | 0.03 |
| 4 | ROC, Regulatory and other expenses including Listing Fee | 0.20 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹50.00 |
| Open | ₹51.10 |
| Low | ₹50.00 |
| High | ₹53.85 |
| Last Trade | ₹50.20 |
Lead Manager Reports
Vanta Bioscience IPO is a SME IPO of 15,12,000 equity shares of the face value of ₹10 aggregating up to ₹8 Crores. The issue is priced at ₹50 per share. The minimum order quantity is 3000.
The IPO opens on Mon, Sep 25, 2017, and closes on Wed, Sep 27, 2017.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Vanta Bioscience IPO using UPI as a payment gateway. Zerodha customers can apply in Vanta Bioscience IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Vanta Bioscience IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Vanta Bioscience IPO opens on Mon, Sep 25, 2017 and closes on Wed, Sep 27, 2017.
Vanta Bioscience IPO lot size is 3000, and the minimum amount required for application is ₹1,50,000.
You can apply in Vanta Bioscience IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Vanta Bioscience IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Vanta Bioscience IPO allotment status.
The Vanta Bioscience IPO listing date is on Fri, Oct 6, 2017.
